BeOne Medicines COO sells 280 ADS at $380

Q: What did BeOne Medicines (ONC) executive Wu Xiaobin report in this Form 4?

Wu Xiaobin, President and COO of BeOne Medicines Ltd. (ONC), reported the sale of 280 ADS on 2026-08-25 at $380.00 per ADS, in an open-market or private transaction, under a Rule 10b5-1 trading plan.

Q: At what price were the BeOne Medicines (ONC) ADS sold in this filing?

The filing reports that 280 American Depositary Shares of BeOne Medicines were sold at a price of $380.00 per ADS on 2026-08-25 in an open-market or private transaction.

Q: How many BeOne Medicines (ONC) shares does Wu Xiaobin hold after the reported transactions?

After the reported transactions, Wu Xiaobin directly holds 1,270,084 Ordinary Shares of BeOne Medicines and indirectly holds 4,000 American Depositary Shares through his wife, as disclosed in the Form 4.

Q: What is the relationship between BeOne Medicines (ONC) ADS and Ordinary Shares?

A footnote states that each American Depositary Share (ADS) represents 13 Ordinary Shares of BeOne Medicines Ltd. This ratio links the ADS traded in U.S. markets to the company’s underlying Ordinary Shares.

Q: Was the BeOne Medicines (ONC) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote explains that the sale of 280 ADS on 2026-08-25 was effected pursuant to a Rule 10b5-1 trading plan adopted by Wu Xiaobin on 2025-11-07, and the filing’s 10b5-1 checkbox is marked true.

BeOne Medicines Ltd. (ONC) officer Wu Xiaobin, President and COO, reported selling 280 American Depositary Shares (ADS) of BeOne Medicines on 2026-08-25 at $380.00 per ADS in an open-market or private transaction.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

BeOne Medicines Ltd. (ONC) officer Wu Xiaobin, President and COO, reported selling 280 American Depositary Shares (ADS) of BeOne Medicines on 2026-08-25 at $380.00 per ADS in an open-market or private transaction. Each ADS represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 2025-11-07. After these transactions, Wu reported direct ownership of 1,270,084 Ordinary Shares and indirect ownership of 4,000 ADS held by his wife.

Insider Trade Summary 10b5-1

Net Seller: 280 shares

Net Sell 4 txns

Insider Wu Xiaobin

Role President and COO

Sold 280 shs ($106K)

Type	Security	Shares	Price	Value
Sale	American Depositary Shares ^{F1, F2}	280	$380.00	$106K
holding	Ordinary Shares	--	--	--
holding	American Depositary Shares ^F1	--	--	--
holding	American Depositary Shares ^F1	--	--	--

Holdings After Transaction: American Depositary Shares — 12,365 shares (Direct); Ordinary Shares — 1,270,084 shares (Direct); American Depositary Shares — 4,000 shares (Indirect, By Wife)

Footnotes (2)

F1. Each American Depositary Share represents 13 Ordinary Shares.
F2. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Key Figures

ADS sold: 280 American Depositary Shares Sale price per ADS: $380.00 per American Depositary Share ADS-to-Ordinary Share ratio: 1 ADS represents 13 Ordinary Shares +4 more

7 metrics

ADS sold 280 American Depositary Shares Sale in open market or private transaction on 2026-08-25

Sale price per ADS $380.00 per American Depositary Share Reported transaction price on 2026-08-25

ADS-to-Ordinary Share ratio 1 ADS represents 13 Ordinary Shares Stated in footnote F1

Net shares sold 280 ADS transactionSummary netBuySellShares for this Form 4

Ordinary Shares held after transaction 1,270,084 Ordinary Shares Direct ownership following the reported transactions

Indirect ADS holdings 4,000 American Depositary Shares Indirect ownership by wife following the reported transactions

Rule 10b5-1 plan adoption date 2025-11-07 Adoption date of trading plan under which the sale was effected

Key Terms

American Depositary Shares, Rule 10b5-1 trading plan, indirect ownership

3 terms

American Depositary Shares financial

"Each American Depositary Share represents 13 Ordinary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Rule 10b5-1 trading plan regulatory

"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

indirect ownership financial

"American Depositary Shares ... ownership_type indirect ... nature_of_ownership "By Wife""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did BeOne Medicines (ONC) executive Wu Xiaobin report in this Form 4?

Wu Xiaobin, President and COO of BeOne Medicines Ltd. (ONC), reported the sale of 280 ADS on 2026-08-25 at $380.00 per ADS, in an open-market or private transaction, under a Rule 10b5-1 trading plan.

At what price were the BeOne Medicines (ONC) ADS sold in this filing?

The filing reports that 280 American Depositary Shares of BeOne Medicines were sold at a price of $380.00 per ADS on 2026-08-25 in an open-market or private transaction.

How many BeOne Medicines (ONC) shares does Wu Xiaobin hold after the reported transactions?

After the reported transactions, Wu Xiaobin directly holds 1,270,084 Ordinary Shares of BeOne Medicines and indirectly holds 4,000 American Depositary Shares through his wife, as disclosed in the Form 4.

What is the relationship between BeOne Medicines (ONC) ADS and Ordinary Shares?

A footnote states that each American Depositary Share (ADS) represents 13 Ordinary Shares of BeOne Medicines Ltd. This ratio links the ADS traded in U.S. markets to the company’s underlying Ordinary Shares.

Was the BeOne Medicines (ONC) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote explains that the sale of 280 ADS on 2026-08-25 was effected pursuant to a Rule 10b5-1 trading plan adopted by Wu Xiaobin on 2025-11-07, and the filing’s 10b5-1 checkbox is marked true.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/27/2026 - 05:13 PM EDT Accepted by SEC EDGAR 08/27/2026 - 05:12 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wu Xiaobin

(Last)

(First)

(Middle)

C/O BEONE MEDICINES I GMBH

AESCHENGRABEN 27, 21ST FLOOR

(Street)

BASEL

4051

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares								1,270,084	D
American Depositary Shares⁽¹⁾								12,365	D
American Depositary Shares⁽¹⁾								4,000	I	By Wife
American Depositary Shares⁽¹⁾	08/25/2026		S⁽²⁾		280	D	$380	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Each American Depositary Share represents 13 Ordinary Shares.

2. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Remarks:

	/s/ Chan Henry Lee, as Attorney-in-Fact	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR